Suven Life Sciences Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 35.39 million compared to INR 20.06 million a year ago. Revenue was INR 39.75 million compared to INR 28.46 million a year ago. Net loss was INR 163.26 million compared to INR 392.09 million a year ago. Basic loss per share from continuing operations was INR 1.12 compared to INR 3.08 a year ago. Diluted loss per share from continuing operations was INR 1.12 compared to INR 3.08 a year ago.